A new meta-analysis from Nautilus compares three leading GLP-1 medications — drugs increasingly prescribed for both diabetes management and weight loss. By synthesizing findings from multiple clinical studies, researchers aim to determine which medication offers the strongest real-world outcomes, examining factors like effectiveness, tolerability, and long-term benefits.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton